Clinical Study

Alliance A221702- A Prospective Trial To Study Rates Of Lymphedema And Regional Recurrence After Sentinel Lymph Node Biopsy And Sentinel Lymph Node Biopsy Followed By Axillary Lymph Node Dissection With And Without Axillary Reverse Mapping

Posted Date: Jul 9, 2020

  • Investigator: Jaime Lewis
  • Specialties: Breast Cancer, Cancer, Oncology
  • Type of Study: Observational/Survey

The goal of this study is to determine the occurrence of post-surgery lymphedema by conical geometric measures in clinical T1-3, N0-3, M0 breast cancer patients undergoing axillary surgery and randomized to Group 1 (no ARM) versus Group II (ARM).


To Be Eligible: Must Be Ct1-3 Patients Undergoing Axillary Surgery, Must Have Ecog 0-2, No Prior History Of Ipsilateral Or Bilateral Invasive Breast Cancer, No History Of Lymphedema Of Either Arm Or Matted Nodes,


Breast Cancer

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.